Systematic genomic analysis of SARS-CoV-2 co-infections throughout the pandemic and segregation of the strains involved
© 2023. The Author(s)..
BACKGROUND: SARS-CoV-2 recombinants involving the divergent Delta and Omicron lineages have been described, and one of them, "Kraken" (XBB.1.5), has recently been a matter of concern. Recombination requires the coexistence of two SARS-CoV-2 strains in the same individual. Only a limited number of studies have focused on the identification of co-infections and are restricted to co-infections involving the Delta/Omicron lineages.
METHODS: We performed a systematic identification of SARS-CoV-2 co-infections throughout the pandemic (7609 different patients sequenced), not biassed towards the involvement of highly divergent lineages. Through a comprehensive set of validations based on the distribution of allelic frequencies, phylogenetic consistency, re-sequencing, host genetic analysis and contextual epidemiological analysis, these co-infections were robustly assigned.
RESULTS: Fourteen (0.18%) co-infections with ≥ 8 heterozygous calls (8-85 HZs) were identified. Co-infections were identified throughout the pandemic and involved an equal proportion of strains from different lineages/sublineages (including pre-Alpha variants, Delta and Omicron) or strains from the same lineage. Co-infected cases were mainly unvaccinated, with mild or asymptomatic clinical presentation, and most were at risk of overexposure associated with the healthcare environment. Strain segregation enabled integration of sequences to clarify nosocomial outbreaks where analysis had been impaired due to co-infection.
CONCLUSIONS: Co-infection cases were identified throughout the pandemic, not just in the time periods when highly divergent lineages were co-circulating. Co-infections involving different lineages or strains from the same lineage were occurring in the same proportion. Most cases were mild, did not require medical assistance and were not vaccinated, and a large proportion were associated with the hospital environment.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
|---|---|
| Enthalten in: |
Genome medicine - 15(2023), 1 vom: 24. Juli, Seite 57 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Peñas-Utrilla, Daniel [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Co-infections |
|---|
| Anmerkungen: |
Date Completed 27.07.2023 Date Revised 27.07.2023 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1186/s13073-023-01198-z |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM359888496 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM359888496 | ||
| 003 | DE-627 | ||
| 005 | 20231226081833.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s13073-023-01198-z |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1199.xml |
| 035 | |a (DE-627)NLM359888496 | ||
| 035 | |a (NLM)37488638 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Peñas-Utrilla, Daniel |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Systematic genomic analysis of SARS-CoV-2 co-infections throughout the pandemic and segregation of the strains involved |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 27.07.2023 | ||
| 500 | |a Date Revised 27.07.2023 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023. The Author(s). | ||
| 520 | |a BACKGROUND: SARS-CoV-2 recombinants involving the divergent Delta and Omicron lineages have been described, and one of them, "Kraken" (XBB.1.5), has recently been a matter of concern. Recombination requires the coexistence of two SARS-CoV-2 strains in the same individual. Only a limited number of studies have focused on the identification of co-infections and are restricted to co-infections involving the Delta/Omicron lineages | ||
| 520 | |a METHODS: We performed a systematic identification of SARS-CoV-2 co-infections throughout the pandemic (7609 different patients sequenced), not biassed towards the involvement of highly divergent lineages. Through a comprehensive set of validations based on the distribution of allelic frequencies, phylogenetic consistency, re-sequencing, host genetic analysis and contextual epidemiological analysis, these co-infections were robustly assigned | ||
| 520 | |a RESULTS: Fourteen (0.18%) co-infections with ≥ 8 heterozygous calls (8-85 HZs) were identified. Co-infections were identified throughout the pandemic and involved an equal proportion of strains from different lineages/sublineages (including pre-Alpha variants, Delta and Omicron) or strains from the same lineage. Co-infected cases were mainly unvaccinated, with mild or asymptomatic clinical presentation, and most were at risk of overexposure associated with the healthcare environment. Strain segregation enabled integration of sequences to clarify nosocomial outbreaks where analysis had been impaired due to co-infection | ||
| 520 | |a CONCLUSIONS: Co-infection cases were identified throughout the pandemic, not just in the time periods when highly divergent lineages were co-circulating. Co-infections involving different lineages or strains from the same lineage were occurring in the same proportion. Most cases were mild, did not require medical assistance and were not vaccinated, and a large proportion were associated with the hospital environment | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Co-infections | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a Segregation | |
| 650 | 4 | |a WGS | |
| 700 | 1 | |a Pérez-Lago, Laura |e verfasserin |4 aut | |
| 700 | 1 | |a Molero-Salinas, Andrea |e verfasserin |4 aut | |
| 700 | 1 | |a Estévez, Agustín |e verfasserin |4 aut | |
| 700 | 1 | |a Sanz, Amadeo |e verfasserin |4 aut | |
| 700 | 1 | |a Herranz, Marta |e verfasserin |4 aut | |
| 700 | 1 | |a Martínez-Laperche, Carolina |e verfasserin |4 aut | |
| 700 | 1 | |a Andrés-Zayas, Cristina |e verfasserin |4 aut | |
| 700 | 1 | |a Veintimilla, Cristina |e verfasserin |4 aut | |
| 700 | 1 | |a Catalán, Pilar |e verfasserin |4 aut | |
| 700 | 1 | |a Alonso, Roberto |e verfasserin |4 aut | |
| 700 | 1 | |a Muñoz, Patricia |e verfasserin |4 aut | |
| 700 | 1 | |a García de Viedma, Darío |e verfasserin |4 aut | |
| 700 | 0 | |a Gregorio Marañón Microbiology-ID COVID 19 Study Group |e verfasserin |4 aut | |
| 700 | 1 | |a Alcalá, Luis |e investigator |4 oth | |
| 700 | 1 | |a Aldámiz, Teresa |e investigator |4 oth | |
| 700 | 1 | |a Álvarez-Uría, Ana |e investigator |4 oth | |
| 700 | 1 | |a Bermúdez, Elena |e investigator |4 oth | |
| 700 | 1 | |a Bouza, Emilio |e investigator |4 oth | |
| 700 | 1 | |a Buenestado-Serrano, Sergio |e investigator |4 oth | |
| 700 | 1 | |a Burillo, Almudena |e investigator |4 oth | |
| 700 | 1 | |a Carrillo, Raquel |e investigator |4 oth | |
| 700 | 1 | |a Cercenado, Emilia |e investigator |4 oth | |
| 700 | 1 | |a Cobos, Alejandro |e investigator |4 oth | |
| 700 | 1 | |a Díez, Cristina |e investigator |4 oth | |
| 700 | 1 | |a Escribano, Pilar |e investigator |4 oth | |
| 700 | 1 | |a Fanciulli, Chiara |e investigator |4 oth | |
| 700 | 1 | |a Galar, Alicia |e investigator |4 oth | |
| 700 | 1 | |a García, Mª Dolores |e investigator |4 oth | |
| 700 | 1 | |a Gijón, Paloma |e investigator |4 oth | |
| 700 | 1 | |a Guillén, Helmuth |e investigator |4 oth | |
| 700 | 1 | |a Guinea, Jesús |e investigator |4 oth | |
| 700 | 1 | |a Irigoyen, Álvaro |e investigator |4 oth | |
| 700 | 1 | |a Kestler, Martha |e investigator |4 oth | |
| 700 | 1 | |a López, Juan Carlos |e investigator |4 oth | |
| 700 | 1 | |a Machado, Marina |e investigator |4 oth | |
| 700 | 1 | |a Marín, Mercedes |e investigator |4 oth | |
| 700 | 1 | |a Martín-Rabadán, Pablo |e investigator |4 oth | |
| 700 | 1 | |a Montilla, Pedro |e investigator |4 oth | |
| 700 | 1 | |a Padilla, Belén |e investigator |4 oth | |
| 700 | 1 | |a Palomino-Cabrera, Rosalía |e investigator |4 oth | |
| 700 | 1 | |a Palomo, María |e investigator |4 oth | |
| 700 | 1 | |a Pérez-Granda, María Jesús |e investigator |4 oth | |
| 700 | 1 | |a Pérez, Leire |e investigator |4 oth | |
| 700 | 1 | |a Reigadas, Elena |e investigator |4 oth | |
| 700 | 1 | |a Rincón, Cristina |e investigator |4 oth | |
| 700 | 1 | |a Rodríguez, Belén |e investigator |4 oth | |
| 700 | 1 | |a Rodríguez, Sara |e investigator |4 oth | |
| 700 | 1 | |a Rodríguez-Grande, Cristina |e investigator |4 oth | |
| 700 | 1 | |a Rojas, Adriana |e investigator |4 oth | |
| 700 | 1 | |a Ruiz-Serrano, María Jesús |e investigator |4 oth | |
| 700 | 1 | |a Sánchez, Carlos |e investigator |4 oth | |
| 700 | 1 | |a Sánchez, Mar |e investigator |4 oth | |
| 700 | 1 | |a Serrano, Julia |e investigator |4 oth | |
| 700 | 1 | |a Tejerina, Francisco |e investigator |4 oth | |
| 700 | 1 | |a Valerio, Maricela |e investigator |4 oth | |
| 700 | 1 | |a Vesperinas, Lara |e investigator |4 oth | |
| 700 | 1 | |a Vicente, Teresa |e investigator |4 oth | |
| 700 | 1 | |a de la Villa, Sofía |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Genome medicine |d 2009 |g 15(2023), 1 vom: 24. Juli, Seite 57 |w (DE-627)NLM187599602 |x 1756-994X |7 nnns |
| 773 | 1 | 8 | |g volume:15 |g year:2023 |g number:1 |g day:24 |g month:07 |g pages:57 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1186/s13073-023-01198-z |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 15 |j 2023 |e 1 |b 24 |c 07 |h 57 | ||